Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor

NCT01982682 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic/Lymphoid Cancer

Interventions

RADIATION: Total-Body Irradiation (TBI)
BIOLOGICAL: Donor Lymphocyte Infusion (DLI)
DRUG: Cyclophosphamide
PROCEDURE: Allogeneic hematopoietic stem cell transplantation (HSCT)
DRUG: Mycophenolate mofetil

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University